June 21 (Reuters) - Livanova Plc :VNS Therapy receives FDA approval for expanded mri labeling.Livanova Plc - its latest VNS Therapy received FDA approval for expanded MRI Labeling.
June 21 (Reuters) - Access Bio Inc <950130.KQ> ::* Says it received patent on June 21, for single-pad strip for an improved lateral flow assay and a test device using the same.* Says patent number is 10-2014-7003992.
June 21 (Reuters) - Kolen Co Ltd <078650.KQ> ::* Says it received U.S. patent on June 21, for photographic lens optical system.* Patent number is 15/196,516.
June 20 (Reuters) - Conformis Inc :Conformis announces FDA 510(k) clearance for itotal hip system.Conformis - expect to leverage synergies with sales representatives, surgeons, hospitals upon limited launch of itotal hip replacement system, which is anticipated for 2019.
June 19(Reuters) - Meganesuper Co Ltd <3318.T>:Says it plans to set up a Tokyo-based consolidated subsidiary, which will be mainly engaged in sales of glasses, contact lens and hearing aid, on June 21.Says this subsidiary will be capitalized at 10 million yen .Business will start from June 21.
June 16 (Reuters) - MEDICREA INTERNATIONAL SA ::GETS FDA CERTIFICATION FOR SPINAL FIXATOR PASS TULIP.
June 16 (Reuters) - MEDICREA INTERNATIONAL SA ::OBTAINS FDA APPROVAL FOR UNID HUB.
June 16 (Reuters) - MEDIRATT AB : :NEW INTERNATIONAL INVESTMENT IN MEDTECH COMPANY MEDIRÄTT.OVER NEXT THREE YEARS, AMBITION IS THAT BRACKNOR WILL INVEST A TOTAL OF SEK 48 MILLION IN MEDIRÄTT.DUBAI-BASED INVESTMENT COMPANY BRACKNOR INVESTMENT GROUP IS INVESTING IN LISTED SWEDISH MEDICAL TECHNOLOGY COMPANY MEDIRÄTT BY DRAWING 400,000 OPTIONS WORTH SEK 2 MILLION.
June 13 (Reuters) - Penumbra Inc -:On June 9, co initiated a voluntary field removal of four lots of its 3D revascularization devices - SEC filing.Voluntary field removal was based on company's identification of an issue involving a raw material component of the devices.Penumbra Inc - does not currently expect that this voluntary action will have material impact on its previously issued revenue guidance - sec filing.The four lots of its 3d revascularization devices were distributed between May 15, 2017 and June 7, 2017.
June 13 (Reuters) - Zimmer Biomet Holdings Inc ::Zimmer Biomet Holdings announces resolution of FDA warning letter related to its Zhejiang, China manufacturing facility.FDA notified company that warning letter dated June 3, 2015 relating to Its Zhejiang, China manufacturing facility has been closed out.Co will continue to take necessary actions to demonstrate commitment to "quality excellence", patient safety, regulatory compliance.